Hongbo Yang

Manager

Boston

Education

Ph.D., biology, and M.S., statistics, University of Illinois at Urbana-Champaign; B.S., biology, Nankai University, P.R. China

Summary of Experience

Dr. Yang specializes in health economics and outcomes research. She has extensive experience in evaluating the clinical and economic impacts of a broad range of diseases and treatments. Her expertise includes analyses of claims, clinical trials, and registry data; medical chart review studies; economic modeling; and the development of health economics and outcomes research strategy. She has led the submission of economic models to multiple health technology assessment agencies (HTAs), including NICE, CADTH, and INESSS. Dr. Yang's work has been published in many peer-reviewed journals and has been featured at various conferences.

Selected Publishing

  • Brentuximab Vedotin Compared with Other Therapies in Relapsed/Refractory Hodgkin Lymphoma Post ASCT: Median Overall Survival Meta-Analysis

    Curr Med Res Opin. 2015 May 7:1-48
    2015

    Bonthapally V, Yang H, Ayyagari R, Tan RD, Cai S, Wu E, Gautam A, Chi A, Huebner D

      View abstract
    Health Care
  • The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas

    Curr Med Res Opin. 2015 Mar; 31(3):537-45
    2015

    Macalalad AR, McAuliffe M, Yang H, Kageleiry A, Zhong Y, Wu EQ, Shonukan O, Bonthapally V.

      View abstract
    Health Care
  • Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous transplant: meta-analysis versus historical data

    Curr Med Res Opin. 2015 May; 31(5):993-1001
    2015

    Bonthapally V, Wu E, Macalalad A, Yang H, Shonukan O, Liu Y, Chi A, Huebner D.

      View abstract
    Health Care
  • The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013

    Am J Obstet Gynecol. 2015 Mar 11
    2015

    Soliman AM, Yang H, Du EX, Kelkar SS, Winkel C 

      View abstract
    Health Care
  • Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases

    Fertil Steril. 2015 Jan; 103(1):163-71
    2015

    Fuldeore M, Yang H, Du EX, Soliman AM, Wu EQ, Winkel C.

      View abstract
    Health Care
  • Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec

    Can J Psychiatry. 2014 Nov; 59(11):597-608
    2014

    Lachaine J, De G, Sikirica V, Van Stralen J, Hodgkins P, Yang H, Heroux J, Ben Amor L.

      View abstract
    Health Care
  • Cost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe

    J Med Econ. 2014 Dec; 17(12):837-45
    2014

    Campone M, Yang H, Faust E, Kageleiry A, Signorovitch JE, Zhang J, Gao H.

      View abstract
    Health Care
  • Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States

    Appl Health Econ Health Policy. 2014 Feb; 12(1):85-93
    2014

    Yang H, Chaudhari P, Zhou ZY, Wu EQ, Patel C, Horn DL.

      View abstract
    Health Care
  • Comparative outcomes of everolimus, temsirolimus and sorafenib as second targeted therapies for metastatic renal cell carcinoma: a US medical record review

    Curr Med Res Opin. 2014 Apr; 30(4):537-45
    2014

    Wong MK, Yang H, Signorovitch JE, Wang X, Liu Z, Liu NS, Qi CZ, George DJ.

      View abstract
    Health Care
  • Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in the United States

    J Med Econ. 2013; 16(2):278-88
    2013

    Xie J, Diener M, De G, Yang H, Wu EQ, Namjoshi M.

      View abstract
    Health Care
  • Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative advanced breast cancer in the United States

    Journal of Medical Economics, 1-26, November 16, 2012
    2012

    Xie J, Diener M, De G, Yang H, Wu EQ, Namjoshi M

      View abstract
    Health CareIntellectual PropertyStrategy, Policy & Analytics
  • Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity

    J Med Econ. 2012; 15(6):1078-87
    2012

    Erder MH, Signorovitch JE, Setyawan J, Yang H, Parikh K, Betts KA, Xie J, Hodgkins P, Wu EQ.

      View abstract
    Health Care
  • Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients

    J Med Econ. 2012; 15(4):786-95
    2012

    Kim Le T, Winfree KB, Yang H, Marynchenko M, Yu AP, Frois C, Wu EQ.

      View abstract
    Health Care
  • Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial

    Br J Dermatol. 2012 Dec; 167(6):1374-81
    2012

    Strober BE, Sobell JM, Duffin KC, Bao Y, Guerin A, Yang H, Goldblum O, Okun MM, Mulani PM 

      View abstract
    Health Care
  • Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs

    Postgrad Med. 2012 Jan; 124(1):124-32
    2012

    Bron M, Marynchenko M, Yang H, Yu AP, Wu EQ

      View abstract
    Health Care
  • Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer

    J Med Econ. 2011; 14(5):542-52
    2011

    Yang H, Yu AP, Wu EQ, Yim YM, Yu E.

      View abstract
    Health Care
  • Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis

    J Med Econ. 2011; 14(3):315-23
    2011

    Yu AP, Yang H, Wu EQ, Setyawan J, Mocarski M, Blum S.

      View abstract
    Health Care
Practices